Fundraising Fox

KdT Ventures

Seed–Series A

Fox Verdict
Sign up to see your fit

Fund manager profile

KdT Ventures is a venture fund manager. SEC filings show 1 venture fund on record, most recently KdT Ventures Fund IV, LP filed June 2024.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

Stage
Seed–Series A
Founded
2017
Tracked investments
5

What they invest in

from 5 of 5 portfolio companies

Biotech ×5Healthtech ×2Advanced Manufacturing ×1AI & Machine Learning ×1Cleantech ×1Climate Tech ×1Deep Tech ×1Longevity ×1

HQs:United States×2

Investments · 5 tracked

founders shown can be your intro path
Solugensolugen.comin𝕏✓ verified

Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale. The company serves customers in energy, chemicals, and related industries with cost-effective alternatives to traditional petrochemical-based manufacturing.

Advanced ManufacturingBiotechCleantechClimate TechHealthtechHouston, US

Sean Hunt(Co-founder)inGaurab Chakrabarti(Co-founder & CEO)in

Dyno Therapeuticsdynotx.comin𝕏

Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases. The company works with pharmaceutical partners including Novartis, Sarepta, Roche, Spark, and Astellas to advance therapies for patients with genetic disorders.

AI & Machine LearningBiotechWatertown, US

Eric Kelsic(CEO & Cofounder)Sam Sinai(Vice President, Head of ML & Cofounder)Adrian Veres(Chief Scientific Officer & Cofounder)George Church(Scientific Cofounder)

Elegenelegenbio.com

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

BiotechDeep Tech

March Biosciencesmarch.bio

March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.

BiotechMedical Devices

Sarah Hein(CEO, Co-Founder)Maksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)

Rejuvenate Biorejuvenatebio.com

Rejuvenate Bio develops gene therapy treatments targeting the root causes of aging to address chronic diseases such as osteoarthritis, heart disease, and cancer in companion animals and humans.

BiotechHealthtechLongevity

Frequently asked questions

What stage does KdT Ventures invest at?
KdT Ventures invests at the Seed, Series A stages.

Similar investors

Featured in lists